| Description |
1 online resource (ix, 113 pages) |
| Series |
Endocrinology research and clinical developments |
|
Endocrinology research and clinical developments.
|
| Contents |
INSULIN RESISTANCE ; INSULIN RESISTANCE ; CONTENTS ; PREFACE ; PATHOPHYSIOLOGICAL BASISFOR ANTIOXIDANT THERAPY OF INSULIN RESISTANCE ; ABSTRACT ; INTRODUCTION ; PATHOPHYSIOLOGY OF INSULIN RESISTANCE ; Insulin-Resistance: Mechanisms of Disease ; Glucose Toxicity in IR; IR and Oxidative Stress Cross-Talking ; Polyol Pathway; Glucosamine Pathway; Kinase C Protein Activation ; TNF-alpha Activate JNK ; Advanced Glycation End Products and Oxidative Stress (AGEs) ; ANTIOXIDANT THERAPY IN INSULIN-RESISTANCE ; Resveratrol ; Antioxidant Effect of Resveratrol in Hepatoprotection |
|
Antioxidant Effect of Resveratrol in Pancreatic Protection Anti-Obesity Effects ; Anti-Diabetic Effects ; Antioxidant Vitamins ; Flavonoids ; Other Antioxidants ; CONCLUSION AND PERSPECTIVES ; REFERENCES ; NEW INSIGHT INTO THE REGULATION OF INSULIN RESISTANCE ; ABSTRACT ; 1. INTRODUCTION ; 2. THE EFFECT OF ENDOCRINE HORMONES ON INSULIN RESISTANCE ; 2.1. Galanin and Insulin Resistance ; 2.2. Ghrelin and Insulin Resistance ; 2. 3. Leptin and Insulin Resistance ; 2.4. Adiponectin and Insulin Resistance ; 2.5. RBP4 and Insulin Resistance |
|
3. THE ROLE OF THE AUTONOMIC NERVOUS SYSTEM IN REGULATING INSULIN RESISTANCE 4. THE GASTROINTESTINAL TRACT MICROBIOTA IN THE DEVELOPMENT OF INSULIN RESISTANCE ; 5. PPARS AND INSULIN RESISTANCE ; 6. VITAMIN D DEFICIENCY IN THE DEVELOPMENT OF INSULIN RESISTANCE ; 7. CURRENT GUIDELINES ON RISK FACTORS FOR INSULIN RESISTANCE, DIRECT AND INDIRECT INSULIN RESISTANCE ASSESSMENT METHODS ; 7.1. CRP; 7.2. Hyperinsulinemic Euglycemic Glucose Clamp ; 7.3. Oral Glucose Tolerance Test; 7. 4. HOMA- Insulin Resistance (IR) ; 8. THE NEW INSIGHT INTO PRIMARY PREVENTION AND THERAPY OF INSULIN RESISTANCE |
|
8.1. SGLT2 8.2. MicroRNAs ; CONCLUSION ; REFERENCES ; INSULIN RESISTANCE AFTER SEVERE BURN INJURY ; ABSTRACT ; ABBREVIATIONS ; INTRODUCTION ; MATERIALS AND METHODS ; RESULTS ; Blood Glucose Levels before and after EIC ; PET Study of Glucose Uptake, Oxygen Extraction Fraction and Blood Flow in Hind Limb Skeletal Muscle ; Changes in Endogenous Glucose Production After EIC ; DISCUSSION ; ACKNOWLEDGMENTS ; REFERENCES ; LIPOPROTEIN LIPASE AND INSULIN RESISTANCE ; ABSTRACT ; INTRODUCTION ; BACKGROUND OF LIPOPROTEIN LIPASE (LPL) ; RELATIONSHIP BETWEEN LPL AND LIPID METABOLISM AND ATHEROSCLEROSIS |
|
EFFECT OF LPL ACTIVATOR NO-1886 ON LPL, LIPID METABOLISM AND ATHEROSCLEROSIS EFFECT OF LPL ACTIVATOR NO-1886 ON FATTY LIVER ; RELATIONSHIP BETWEEN LPL AND OBESITY AND INSULIN RESISTANCE ; REFERENCES ; INDEX |
| Bibliography |
Includes bibliographical references |
| Notes |
Print version record |
| Subject |
Insulin resistance.
|
|
Insulin Resistance
|
|
HEALTH & FITNESS -- Diseases -- Diabetes.
|
|
Insulin resistance
|
| Form |
Electronic book
|
| Author |
Freeman, John
|
|
Newman, Scott
|
| LC no. |
2012952790 |
| ISBN |
9781624174087 |
|
1624174086 |
|
